Philip Morris International Inc has a consensus price target of $107.15 based on the ratings of 14 analysts. The high is $120 issued by Goldman Sachs on January 25, 2023. The low is $86.5 issued by UBS on January 23, 2024. The 3 most-recent analyst ratings were released by Stifel, Societe Generale, and UBS on April 24, 2024, February 13, 2024, and January 23, 2024, respectively. With an average price target of $96.33 between Stifel, Societe Generale, and UBS, there's an implied -12.03% downside for Philip Morris International Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/24/2024 | Buy Now | 5.01% | Stifel | Matthew Smith | $108 → $115 | Maintains | Buy | Get Alert |
03/05/2024 | Buy Now | — | Argus Research | David Coleman | — | Downgrade | Buy → Hold | Get Alert |
02/13/2024 | Buy Now | -20.1% | Societe Generale | Chas Manso | → $87.5 | Upgrade | Sell → Hold | Get Alert |
01/23/2024 | Buy Now | -21.01% | UBS | Nik Oliver | $105 → $86.5 | Downgrade | Buy → Sell | Get Alert |
11/29/2023 | Buy Now | 5.01% | JP Morgan | Jared Dinges | $110 → $115 | Maintains | Overweight | Get Alert |
11/16/2023 | Buy Now | -13.25% | Redburn Atlantic | Jacob de Klerk | → $95 | Initiates | → Neutral | Get Alert |
10/13/2023 | Buy Now | -4.12% | Jefferies | Owen Bennett | $111 → $105 | Maintains | Buy | Get Alert |
10/05/2023 | Buy Now | 2.27% | UBS | Nik Oliver | $116 → $112 | Maintains | Buy | Get Alert |
10/02/2023 | Buy Now | 4.1% | Stifel | Matthew Smith | → $114 | Reiterates | Buy → Buy | Get Alert |
10/02/2023 | Buy Now | 3.19% | Morgan Stanley | Pamela Kaufman | $118 → $113 | Maintains | Overweight | Get Alert |
09/21/2023 | Buy Now | -8.68% | Barclays | Gaurav Jain | $115 → $100 | Maintains | Overweight | Get Alert |
08/22/2023 | Buy Now | 1.36% | Jefferies | Owen Bennett | $113 → $111 | Maintains | Buy | Get Alert |
06/27/2023 | Buy Now | 7.75% | Morgan Stanley | Pamela Kaufman | $118 → $118 | Reiterates | Overweight → Overweight | Get Alert |
06/20/2023 | Buy Now | 6.84% | Citigroup | Simon Hales | $109 → $117 | Upgrade | Neutral → Buy | Get Alert |
04/14/2023 | Buy Now | 4.1% | Stifel | Matthew Smith | → $114 | Reinstates | → Buy | Get Alert |
04/13/2023 | Buy Now | 4.1% | Stifel | Philip Morris | → $114 | Reinstates | → Buy | Get Alert |
03/30/2023 | Buy Now | 5.93% | JP Morgan | Jared Dinges | $109 → $116 | Upgrade | Neutral → Overweight | Get Alert |
03/01/2023 | Buy Now | 5.93% | UBS | Nik Oliver | $106 → $116 | Upgrade | Neutral → Buy | Get Alert |
02/13/2023 | Buy Now | -0.47% | JP Morgan | Jared Dinges | $95 → $109 | Maintains | Neutral | Get Alert |
02/02/2023 | Buy Now | 7.75% | Morgan Stanley | Pamela Kaufman | $109 → $118 | Maintains | Overweight | Get Alert |
01/25/2023 | Buy Now | 9.58% | Goldman Sachs | Bonnie Herzog | $95 → $120 | Upgrade | Neutral → Buy | Get Alert |
01/19/2023 | Buy Now | 7.75% | Jefferies | Owen Bennett | → $118 | Upgrade | Hold → Buy | Get Alert |
12/13/2022 | Buy Now | -0.47% | Citigroup | Simon Hales | → $109 | Reinstates | → Neutral | Get Alert |
11/15/2022 | Buy Now | 0.45% | Argus Research | David Coleman | → $110 | Upgrade | Hold → Buy | Get Alert |
11/02/2022 | Buy Now | -0.47% | Morgan Stanley | Pamela Kaufman | $102 → $109 | Maintains | Overweight | Get Alert |
10/14/2022 | Buy Now | -4.12% | Stifel | Christopher Growe | $115 → $105 | Maintains | Buy | Get Alert |
10/14/2022 | Buy Now | -6.86% | Morgan Stanley | Pamela Kaufman | $112 → $102 | Maintains | Overweight | Get Alert |
07/19/2022 | Buy Now | -9.6% | Jefferies | Owen Bennett | $107 → $99 | Maintains | Hold | Get Alert |
04/22/2022 | Buy Now | 2.27% | Morgan Stanley | Pamela Kaufman | $104 → $112 | Maintains | Overweight | Get Alert |
03/25/2022 | Buy Now | -4.12% | Stifel | Christopher Growe | $115 → $105 | Maintains | Buy | Get Alert |
03/25/2022 | Buy Now | -5.03% | Morgan Stanley | Pamela Kaufman | $115 → $104 | Maintains | Overweight | Get Alert |
03/22/2022 | Buy Now | -8.68% | Goldman Sachs | Bonnie Herzog | $116 → $100 | Downgrade | Buy → Neutral | Get Alert |
03/07/2022 | Buy Now | 0.45% | JP Morgan | Jared Dinges | $130 → $110 | Downgrade | Overweight → Neutral | Get Alert |
02/17/2022 | Buy Now | 0.45% | UBS | Nik Oliver | $95 → $110 | Maintains | Neutral | Get Alert |
01/26/2022 | Buy Now | 5.01% | Morgan Stanley | Pamela Kaufman | $105 → $115 | Maintains | Overweight | Get Alert |
12/02/2021 | Buy Now | -4.12% | Morgan Stanley | Pamela Kaufman | — | Maintains | Overweight | Get Alert |
08/19/2021 | Buy Now | 9.58% | Deutsche Bank | — | — | Maintains | Buy | Get Alert |
The latest price target for Philip Morris Intl (NYSE:PM) was reported by Stifel on April 24, 2024. The analyst firm set a price target for $115.00 expecting PM to rise to within 12 months (a possible 6.48% upside). 12 analyst firms have reported ratings in the last year.
The latest analyst rating for Philip Morris Intl (NYSE:PM) was provided by Stifel, and Philip Morris Intl maintained their buy rating.
The last upgrade for Philip Morris International Inc happened on February 13, 2024 when Societe Generale raised their price target to $87.5. Societe Generale previously had a sell for Philip Morris International Inc.
The last downgrade for Philip Morris International Inc happened on March 5, 2024 when Argus Research changed their price target from N/A to N/A for Philip Morris International Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Philip Morris Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Philip Morris Intl was filed on April 24, 2024 so you should expect the next rating to be made available sometime around April 24, 2025.
While ratings are subjective and will change, the latest Philip Morris Intl (PM) rating was a maintained with a price target of $108.00 to $115.00. The current price Philip Morris Intl (PM) is trading at is $108.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.